Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Cancer Epidemiol Biomarkers Prev · ISSN (e) 1538-7755 · 81 papers in corpus
observational 2013
doi:10.1158/1055-9965.epi-13-0509 ·PMID:23983241

BACKGROUND: The rodent carcinogen acrylamide was discovered in 2002 in commonly consumed foods. Epidemiologic studies have observed positive associations between acrylamide intake and endometrial, ovarian, and breast cancer risks, which sug…

other 2013
doi:10.1158/1055-9965.epi-13-0391 ·PMID:23880734

BACKGROUND: Ovarian carcinoma is composed of five major histologic types, which associate with outcome and predict therapeutic response. Our aim was to evaluate histologic type assessments across the centers participating in the Ovarian Tum…

meta-analysis 2013
doi:10.1158/1055-9965.EPI-12-1030-T ·PMID:23462924

BACKGROUND: There are several well-established environmental risk factors for ovarian cancer, and recent genome-wide association studies have also identified six variants that influence disease risk. However, the interplay between such risk…

meta-analysis 2013
doi:10.1158/1055-9965.epi-12-1144 ·PMID:23093546

Knowledge integration includes knowledge management, synthesis, and translation processes. It aims to maximize the use of collected scientific information and accelerate translation of discoveries into individual and population health benef…

observational 2013
doi:10.1158/1055-9965.epi-13-0192 ·PMID:23917454

BACKGROUND: Six gene expression subtypes of invasive epithelial ovarian cancer were recently defined using microarrays by Tothill and colleagues. The Cancer Genome Atlas (TCGA) project subsequently replicated these subtypes and identified a…

observational 2013
doi:10.1158/1055-9965.epi-12-0903 ·PMID:23221126

BACKGROUND: Experimental and epidemiologic evidence have suggested that chronic inflammation may play a critical role in endometrial carcinogenesis. METHODS: To investigate this hypothesis, a two-stage study was carried out to evaluate sin…

diagnostic-accuracy 2013
doi:10.1158/1055-9965.epi-12-1368 ·PMID:23878295

BACKGROUND: Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer-related death in females and leading gynecologic cause of cancer-related death. Despite the identification of a number of serum biomarkers, methods to identify…

meta-analysis 2012
doi:10.1158/1055-9965.epi-11-1059 ·PMID:22473761

BACKGROUND: A number of studies have reported on the association between smoking and meningioma risk, with inconsistent findings. We examined the effect of gender on the association between cigarette smoking and risk of intracranial meningi…

meta-analysis 2012
doi:10.1158/1055-9965.epi-11-0834 ·PMID:22028402

Estrogens may influence gastric cancer risk, but published studies are inconclusive. We therefore carried out a meta-analysis addressing the associations of gastric cancer in women with menstrual and reproductive factors and with use of est…

observational 2012
doi:10.1158/1055-9965.epi-11-0867 ·PMID:22267287

BACKGROUND: Telomeres protect chromosomal ends, shorten with cellular division, and signal cellular senescence, but unchecked telomere attrition can lead to telomere dysfunction, upregulation of telomerase, and carcinogenesis. Shorter telom…

observational 2012
doi:10.1158/1055-9965.epi-12-0426 ·PMID:22707710

BACKGROUND: Previous studies examining associations between use of fertility drugs and ovarian cancer risk have provided conflicting results. We used data from a large case-control study to determine whether fertility drug use significantly…

observational 2012
doi:10.1158/1055-9965.epi-12-0390-t ·PMID:22665579

BACKGROUND: Chronic inflammation may play an etiologic role in ovarian and endometrial cancer, and it is hypothesized that nonsteroidal anti-inflammatory drugs (NSAID) decrease the risk of developing these malignancies. No prospective study…

other 2011
doi:10.1158/1055-9965.epi-11-0139 ·PMID:21846819

BACKGROUND: According to extensive epidemiologic data, infertility is associated with increased ovarian cancer risk. Previous studies showed that both women with infertility and those with ovarian cancer have autoantibodies to ovarian antig…

observational 2011
doi:10.1158/1055-9965.epi-10-1180 ·PMID:21467242

BACKGROUND: Factors contributing to chronic inflammation appear to be associated with increased risk of ovarian cancer. The purpose of this study was to assess the association between circulating levels of inflammation mediators and subsequ…

observational 2011
doi:10.1158/1055-9965.epi-10-0793 ·PMID:21119072

BACKGROUND: In addition to mediating aspects of physiologic and pathologic angiogenesis, the VEGF family also contributes to carcinogenesis. METHODS: We comprehensively characterized genetic variation across four VEGF family genes and eval…

diagnostic-accuracy 2011
doi:10.1158/1055-9965.EPI-11-0635 ·PMID:22028406

BACKGROUND: The aim of this work was to analyze the diagnostic and prognostic value of serum human epididymis protein 4 (HE4) and Risk for Ovarian Malignancy Algorithm (ROMA) in epithelial ovarian cancer (EOC). METHODS: Preoperative serum …

observational 2010
doi:10.1158/1055-9965.epi-10-0068 ·PMID:20501761

BACKGROUND: The surface epithelial glycoprotein MUC1 becomes overexpressed and hypoglycosylated in adenocarcinomas; similar changes occur during nonmalignant inflammatory events. Antibodies developed against tumor-like MUC1 in response to s…

observational 2010
doi:10.1158/1055-9965.epi-09-0750 ·PMID:20086106

BACKGROUND: Endometrioid epithelial ovarian cancer (EEOC) is frequently diagnosed in conjunction with endometriosis and is suggested to arise during the process of endometriosis. This study evaluates the clinical manifestations, including e…

observational 2010
doi:10.1158/1055-9965.epi-09-0976 ·PMID:20142241

BACKGROUND: Several epidemiologic studies have shown inverse associations between use of nonsteroidal anti-inflammatory drugs (NSAID) and incident ovarian cancer, but the results are inconsistent. There have been only a few studies examinin…

diagnostic-accuracy 2009
doi:10.1158/1055-9965.EPI-08-0653 ·PMID:19336561

Comparative proteomics identified the vitamin E-binding plasma protein afamin as a potential novel tumor marker for ovarian cancer. In addition, we observed in a previous small study decreased plasma concentrations of apolipoprotein A-IV (a…

observational 2009
doi:10.1158/1055-9965.epi-09-0244 ·PMID:19435861

The matrix metalloproteinases (MMP) function as regulators of the dynamic tissue remodeling that occurs in the endometrial lining of the uterus during the normal human menstrual cycle; dysregulation of the MMPs is thought to contribute to t…

observational 2009
doi:10.1158/1055-9965.epi-08-1214 ·PMID:19383883

Hormone receptor expression in tumors may offer etiologic information for ovarian cancer, particularly in light of known associations with hormonal and reproductive risk factors. Tissue microarrays constructed from 157 paraffin-embedded blo…

observational 2009
doi:10.1158/1055-9965.epi-08-0936 ·PMID:19383893

We studied the relation of medical conditions related to obesity and medications used for these conditions with endometrial cancer. We also investigated the association of other medical conditions and medications with risk. This U.S. popula…

observational 2009
doi:10.1158/1055-9965.epi-08-0996 ·PMID:19240232

Detailed characterization of estrogen dynamics during the transition to menopause is an important step toward understanding its potential implications for reproductive cancers developing in the transition years. We conducted a 5-year prospe…

meta-analysis 2008
doi:10.1158/1055-9965.epi-07-2922 ·PMID:18628412

OBJECTIVES: To describe prevalence and estimated attribution of human papillomavirus (HPV) types in U.S. cervical, vaginal, and vulvar precancers and cancers. METHODS: U.S. studies reporting HPV typing for cervical intraepithelial neoplasi…